🔗 Permalink

Inventor profile of:

Patrick Van Berkel

City:

Utrecht

Country:

Netherlands

Published Applications:

Last publication date:

2025-02-27

Top Assignees for applications by Patrick Van Berkel

The entities that hold a legal rights for patent applications filed by inventor Van Berkel Patrick:

GENMAB A/S 11 Copenhagen, Denmark
GENMAB A/S 5 Copenhagen K, Denmark
GENMAB A/S 4 Copenhagen V, Denmark
GENMAB A/S 2 Valby, Denmark
Muriel VAN KAMPEN 1 Utrecht, Netherlands
Patrick PRIEM 1 Utrecht, Netherlands
Aran Frank LABRIJN 1 Utrecht, Netherlands
Joost J. NEIJSSEN 1 Utrecht, Netherlands
Janine SCHUURMAN 1 Utrecht, Netherlands
Paul PARREN 1 Utrecht, Netherlands
Patrick VAN BERKEL 1 Utrecht, Netherlands
Werner L. VOS 1 Utrecht, Netherlands
Arnout GERRITSEN 1 Utrecht, Netherlands
Joyce I. MEESTERS 1 Utrecht, Netherlands
GENMAG A/S 1 Copenhagen V, Denmark
Michael GRAMER 1 Lino Lakes, MN United States
Amitava KUNDU 1 Maple Grove, MN United States
Ewald T.J. VAN DEN BREMER 1 Utrecht, Netherlands

Recent patent applications by Van Berkel Patrick

Patrick Van Berkel from Utrecht, NL has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-02-27

US20250066506A1

Chemistry; metallurgy

BISPECIFIC ANTIBODIES AGAINST HER2

#2 | 2024-09-05

US20240294661A1

Chemistry; metallurgy

HUMAN ANTIBODY DRUG CONJUGATES AGAINST TISSUE FACTOR

#3 | 2024-06-27

US20240209117A1

Chemistry; metallurgy

HETERODIMERIC ANTIBODY FC-CONTAINING PROTEINS AND METHODS FOR PRODUCTION THEREOF

#4 | 2023-07-20

US20230227495A1

Chemistry; metallurgy

PRODUCTION OF HETERODIMERIC PROTEINS

#5 | 2022-12-15

US20220396629A1

Chemistry; metallurgy

RECOMBINANT MONOVALENT ANTIBODIES AND METHODS FOR PRODUCTION THEREOF

#6 | 2022-10-13

US20220323582A1

Human necessities

HUMAN ANTIBODIES AND ANTIBODY-DRUG CONJUGATES AGAINST CD74

#7 | 2022-06-09

US20220177585A1

Chemistry; metallurgy

POTENCY ASSAYS FOR ANTIBODY DRUG SUBSTANCE BINDING TO AN FC RECEPTOR

#8 | 2021-12-23

US20210395384A1

Chemistry; metallurgy

HUMAN ANTIBODY DRUG CONJUGATES AGAINST TISSUE FACTOR

#9 | 2021-10-21

US20210324105A1

Chemistry; metallurgy

BISPECIFIC ANTIBODIES AGAINST HER2

#10 | 2020-08-20

US20200262932A1

Chemistry; metallurgy

Heterodimeric antibody Fc-containing proteins and methods for production thereof

#11 | 2020-04-30

US20200131253A1

Chemistry; metallurgy

Modulation of complement-dependent cytotoxicity through modifications of the C-terminus of antibody heavy chains

#12 | 2020-02-13

US20200048304A1

Chemistry; metallurgy

Production of heterodimeric proteins

#13 | 2019-10-17

US20190315880A1

Chemistry; metallurgy

HUMAN ANTIBODY DRUG CONJUGATES AGAINST TISSUE FACTOR

#14 | 2019-06-06

US20190169298A1

Chemistry; metallurgy

RECOMBINANT MONOVALENT ANTIBODIES AND METHODS FOR PRODUCTION THEREOF

#15 | 2017-12-28

US20170369590A1

Chemistry; metallurgy

BISPECIFIC ANTIBODIES AGAINST HER2

#16 | 2017-12-21

US20170362319A1

Chemistry; metallurgy

POTENCY ASSAYS FOR ANTIBODY DRUG SUBSTANCE BINDING TO AN FC RECEPTOR

#17 | 2017-08-17

US20170233497A1

Chemistry; metallurgy

Heterodimeric antibody Fc-containing proteins and methods for production thereof

#18 | 2017-06-22

US20170173151A1

Human necessities

HUMAN ANTIBODIES AND ANTIBODY-DRUG CONJUGATES AGAINST CD74

#19 | 2017-05-18

US20170136130A1

Human necessities

HUMAN ANTIBODY DRUG CONJUGATES AGAINST TISSUE FACTOR

#20 | 2017-02-09

US20170037138A1

Chemistry; metallurgy

Recombinant IgG4 monovalent antibodies

#21 | 2016-03-10

US20160067349A1

Human necessities

Human antibody drug conjugates against tissue factor

#22 | 2016-02-18

US20160046727A1

Chemistry; metallurgy

HETERODIMERIC ANTIBODY FC-CONTAINING PROTEINS AND METHODS FOR PRODUCTION THEREOF

#23 | 2014-10-09

US20140303356A1

Chemistry; metallurgy

Production of heterodimeric proteins

#24 | 2014-09-18

US20140271623A1

Chemistry; metallurgy

Modulation of complement-dependent cytotoxicity through modifications of the C-terminus of antibody heavy chains

#25 | 2014-06-19

US20140170148A1

Chemistry; metallurgy

BISPECIFIC ANTIBODIES AGAINST HER2

#26 | 2014-01-30

US20140030273A1

Chemistry; metallurgy

Human antibodies and antibody-drug conjugates against CD74

#27 | 2013-04-25

US20130101608A1

Human necessities

Human antibody drug conjugates against tissue factor

#28 | 2013-02-14

US20130039913A1

Chemistry; metallurgy

Heterodimeric antibody Fc-containing proteins and methods for production thereof

#29 | 2011-02-24

US20110045007A1

Chemistry; metallurgy

FUSION OR LINKED PROTEINS WITH EXTENDED HALF LIFE

#30 | 2010-12-23

US20100325744A1

Chemistry; metallurgy

NON-GLYCOSYLATED RECOMBINANT MONOVALENT ANTIBODIES

#31 | 2010-12-02

US20100306867A1

Chemistry; metallurgy

Recombinant IgG4 monovalent antibodies

#32 | 2010-11-18

US20100291023A1

Chemistry; metallurgy

METHOD FOR EXTENDING THE HALF-LIFE OF EXOGENOUS OR ENDOGENOUS SOLUBLE MOLECULES

#33 | 2010-10-07

US20100255012A1

Chemistry; metallurgy

RECOMBINANT FUCOSE MODIFIED MONOVALENT HALF-ANTIBODIES OBTAINED BY MOLECULAR ENGINEERING

#34 | 2010-01-21

US20100015644A1

Chemistry; metallurgy

Potency assays for antibody drug substance binding to an Fc receptor

#35 | 2009-09-10

US20090226421A1

Chemistry; metallurgy

Recombinant monovalent antibodies and methods for production thereof

InventorID:

89196 ⎘